Cost-Effectiveness Of Using Haematopoetic Growth Factor In Consolidation Therapy Of Patients With Acute Myeloid Leukemia
10.1501/Tipfak_0000000843
Received Date: 06.03.2012 Accepted Date: 26.02.2014 J Ankara Univ Fac Med 2013;66(2):65-70
Keywords: Haematopoetic growth factor, AML, cost-effectiveness